Zobrazeno 1 - 10
of 26 143
pro vyhledávání: '"11"'
Autor:
Christine A. Iacobuzio-Donahue, Francesco Maura, Ahmet Dogan, Heather Landau, Amit Verma, Rachel Zeig-Owens, Shani Irby, Kylee H Maclachlan, Orsolya Giricz, Sohrab P. Shah, David J. Prezant, Benjamin Diamond, Even H Rustad, Jessica Hong, Andriy Derkach, Venkata Yellapantula, Mayris P. Webber, Elli Papaemmanuil, Ola Landgren, David G. Goldfarb, Michael Crane, Urvi A Shah, Laura Crowley, Malin Hultcrantz, Yanming Zhang
Publikováno v:
Clin Cancer Res
Purpose: The World Trade Center (WTC) attack of September 11, 2001 created an unprecedented environmental exposure to known and suspected carcinogens. High incidence of multiple myeloma and precursor conditions has been reported among first responder
Autor:
Virginie Eclache, John Boudjarane, Naïs Prade, Stéphanie Struski, Laetitia Largeaud, Cyril Broccardo, Joop H. Jansen, Christine Terré, Marie-Agnès Collonge-Rame, Pierre-Yves Juvin, Dominique Penther, Stéphanie Lagarde, Antoine Ittel, Véronique Mansat-De Mas, G Ameye, Isabelle Luquet, Marina Lafage-Pochitaloff, Carole Barin, David Rombaut, Bastien Gerby, Carine Gervais, Steven Richebourg, Oliver M. Dovey, Pierre Bories, Christine Lefebvre, Isabelle Radford-Weiss, Audrey Bidet, Isabelle Tigaud, George S. Vassiliou, Benedicte Ribourtout, Tobias Tekath, Michaela Fontenay, Lucienne Michaux, Sylvie Hébrard, Hélène Antoine-Poirel, Laura Jamrog, Vincent Fregona, Nathalie Nadal, Eric Delabesse, Véronique Baccini, Kosuke Yusa
Publikováno v:
Blood Advances, 6, 2, pp. 386-398
Blood Advances
Blood Advances, 6, 386-398
Blood Advances, The American Society of Hematology, 2021, ⟨10.1182/bloodadvances.2021005311⟩
Blood Advances
Blood Advances, 6, 386-398
Blood Advances, The American Society of Hematology, 2021, ⟨10.1182/bloodadvances.2021005311⟩
Key Points We detail at clinical, cytological, cytogenetic, and molecular levels 113 cases of MDS and MDS/MPN with del(11q), a rare recurrent event.CADM1, a tumor suppressor gene identified initially in solid tumors, ATM, CBL, and KMT2A are deleted a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a801474f49c15e8392848015e288927
https://repository.ubn.ru.nl/handle/2066/244555
https://repository.ubn.ru.nl/handle/2066/244555
Autor:
Carlos E. Bueso-Ramos, Yang O. Huh, L. Jeffrey Medeiros, Ali Sakhdari, Chi Young Ok, Zhenya Tang
Publikováno v:
Cancer Genetics. 238:18-22
AML and MDS are most common myeloid neoplasms that affect mainly older patients. Overexpression of certain proto-oncogenes plays an indispensable role in tumorigenesis and overexpression can be a consequence of gene rearrangement, amplification and/o
Autor:
Clara D. Bloomfield, Bayard L. Powell, Andrew J. Carroll, Shelley Orwick, Ann-Kathrin Eisfeld, Jessica Kohlschmidt, Bhavana Bhatnagar, Dimitrios Papaioannou, Richard Stone, Deedra Nicolet, Krzysztof Mrózek, John C. Byrd, Jonathan E. Kolitz, Christopher J. Walker, James S. Blachly
Publikováno v:
Leukemia. 34:358-368
Sole trisomies of chromosomes 4, 8, 11, 13 and 21 account for 89–95% of all sole trisomies in adult AML patients. We analyzed clinical and molecular characteristics of 138 de novo AML patients with sole +4, +8, +11, +13 or +21, and compared them wi
Autor:
Mong Heng Wang, Shu Hsien Huang, Jing Lun Yen, Fan Li Lin, Chih Kuang Chen, Ping Huei Tsai, Po Jen Hsueh, Che Jen Hsiao, Yueh-Hsiung Kuo, George Hsiao
Publikováno v:
Molecules, Vol 26, Iss 2970, p 2970 (2021)
Molecules
Volume 26
Issue 10
Molecules
Volume 26
Issue 10
Intracerebral hemorrhage (ICH) is a devastating neurological disorder characterized by an exacerbation of neuroinflammation and neuronal injury, for which few effective therapies are available at present. Inhibition of excessive neuroglial activation
Publikováno v:
Histopathology. Wiley
Histopathology
Histopathology
Aims Primary intraosseous rhabdomyosarcoma (RMS) is a rare entity defined by EWSR1/FUS-TFCP2 or, less commonly, MEIS1-NCOA2 fusions. The lesions often show a hybrid spindle and epithelioid phenotype, frequently coexpress myogenic markers, ALK, and cy
Autor:
Amy Winship, Eva Dimitriadis
Publikováno v:
Journal of Reproductive Immunology. 125:32-38
Preeclampsia is a dangerous pregnancy complication, which is often associated with fetal growth restriction and can have serious life-long effects for both mother and baby. While the establishment of the placenta in the first trimester is the sentine
Publikováno v:
Open Medicine
Open Medicine, Vol 16, Iss 1, Pp 610-617 (2021)
Open Medicine, Vol 16, Iss 1, Pp 610-617 (2021)
Nocardiosis is a rare, life-threatening, opportunistic, and suppurative infection. Its clinical manifestation lacks specificity, which makes early diagnosis difficult. A retrospective analysis of the clinical records of 11 patients with nocardiosis a
Autor:
Saheed B.A. Oseni, Oladapo Adedayo Kolawole, Musa Tawakalit Lily, Olusola Adetunji Oyedeji, Olamide Kayode
Publikováno v:
Nigerian Medical Journal; Vol. 61 No. 5 (2020); 284-287
Nigerian Medical Journal : Journal of the Nigeria Medical Association
Nigerian Medical Journal : Journal of the Nigeria Medical Association
We report the case of an 11-year-old boy with proximal myopathy, heliotrope, and Gottron papule-like rashes. Serum chemistry revealed muscle enzyme elevations, whereas muscle biopsy histology showed necrosis and inflammation, which were in keeping wi
Autor:
Hyun-Jung Kim, Ali Al-Mourabit, Cristina Florean, Kyung Rok Kim, Byung Woo Han, Cécile Debitus, Mario Dicato, Marc Diederich, Michael Schnekenburger, Céline Moriou
Publikováno v:
Marine drugs
Marine drugs, MDPI, 2018, 16 (12), pp.518. ⟨10.3390/md16120518⟩
Marine Drugs
Volume 16
Issue 12
Marine drugs, 2018, 16 (12), pp.518. ⟨10.3390/md16120518⟩
Marine Drugs, Vol 16, Iss 12, p 518 (2018)
Marine Drugs (1660-3397) (Mdpi), 2018-12, Vol. 16, N. 12, P. 518 (19p.)
Marine drugs, MDPI, 2018, 16 (12), pp.518. ⟨10.3390/md16120518⟩
Marine Drugs
Volume 16
Issue 12
Marine drugs, 2018, 16 (12), pp.518. ⟨10.3390/md16120518⟩
Marine Drugs, Vol 16, Iss 12, p 518 (2018)
Marine Drugs (1660-3397) (Mdpi), 2018-12, Vol. 16, N. 12, P. 518 (19p.)
Treatment of acute myeloid leukemia (AML) patients is still hindered by resistance and relapse, resulting in an overall poor survival rate. Recently, combining specific B-cell lymphoma (Bcl)-2 inhibitors with compounds downregulating myeloid cell leu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297fdc840a54db8c962da0cb240a700e
https://hal.archives-ouvertes.fr/hal-02339755/document
https://hal.archives-ouvertes.fr/hal-02339755/document